Complete regression of metastatic de-differentiated liposarcoma with engineered mesenchymal stromal cells with dTRAIL and HSV-TK

De-differentiated liposarcoma (DDLPS) is a rare cancer with high rates of recurrence and metastasis. Currently, treatment with doxorubicin-ifosphamide, following surgical resection, is routinely performed. However, clinical treatment of these refractory cancers require further study. We investigated...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Transl Res
Main Authors: Jo, Eun Byeol, Lee, Hyunjoo, Lee, Kyo Won, Kim, Sung Joo, Hong, Doopyo, Park, Jae Berm
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7407704/
https://ncbi.nlm.nih.gov/pubmed/32774752
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki